Make money doing the work you believe in

IMMX is an exciting single asset CAR-T cell therapy company with a pivotal phase 2 readout in Q3

Immix Biopharma (IMMX) - Scientific Deep Dive for NXC-201 and Pipeline Products
May 12
at
12:06 PM
Relevant people

Log in or sign up

Join the most interesting and insightful discussions.